Parmar Kush's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Jul 1, 2025
- Accession no.
- 0001415889-25-018824
- Filed
- Jul 1, 2025
- Trade date
- Jun 27-Jul 1, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $866.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parmar KushCIK 0001664281 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | Common Stock | SSaleDisposed | −55,735 | $6.91 | −$385,128.85 | 3,220,287 | Indirect | |
| Jun 27, 2025 | Common Stock | SSaleDisposed | −19,265 | $6.91 | −$133,121.15 | 1,113,092 | Indirect | |
| Jun 30, 2025 | Common Stock | SSaleDisposed | −18,578 | $6.81 | −$126,516.18 | 3,201,709 | Indirect | |
| Jun 30, 2025 | Common Stock | SSaleDisposed | −6,422 | $6.81 | −$43,733.82 | 1,106,670 | Indirect | |
| Jul 1, 2025 | Common Stock | SSaleDisposed | −18,578 | $7.12 | −$132,275.36 | 3,183,131 | Indirect | |
| Jul 1, 2025 | Common Stock | SSaleDisposed | −6,422 | $7.12 | −$45,724.64 | 1,100,248 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.